US Patent 11779629 Compositions comprising cyclic peptides derived from an A-beta peptide
Patent 11779629 was granted and assigned to The University Of British Columbia on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+75 properties)
Article (+331 characters)
US Patent 11779629 Compositions comprising cyclic peptides derived from an A-beta peptide
Article
Patent abstract
The disclosure pertains to methods of treating or preventing a disease or condition associated with and/or induced by soluble A-beta oligomer such as Alzheimer's disease by administering to a subject in need thereof conformation specific and/or selective antibodies or binding fragments thereof and related products.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Neil R. Cashman
Date of Patent
October 10, 2023
Patent Application Number
16999849
Date Filed
August 21, 2020
Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11779629 Compositions comprising cyclic peptides derived from an A-beta peptide
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.